Breast cancer is the most frequently diagnosed neoplastic disease in women around
menopause often leading to a significant reduction of these women's ability to function …

Before the advent of the human epidermal growth factor receptor 2 (HER2)-targeted
monoclonal antibody trastuzumab, HER2-positive breast cancers were difficult to treat and …

Background Male breast cancer accounts for less than 1% of all breast cancers, yet males
have a worse prognosis than females with breast cancer. Methods Using the 1988–2003 …

OBJECTIVE. The purposes of this article are to describe two cases of breast cancer in male-
to-female transsexuals and to review eight cases previously reported in the literature …

This review concerns the effects on vision and the eye of medications prescribed at three
phases of treatment for women with early-stage breast cancer (BC):(1) adjuvant cytotoxic …

Background The male breast cancer (MBC) is a rare and represents less than 1% of all
malignancies in men and only 1% of all breast cancers incident. We illustrate the experience …

Purpose Breast cancer treatment has progressed significantly over the past 20 years.
However, knowledge regarding male breast cancer (MBC) is sparse because of its rarity …

Male breast cancer is an uncommon malignancy; little is known regarding hormonal
manipulations for tamoxifen-resistant male breast cancer patients. This is the first pooled …

Background: Data regarding the safety and effectiveness of aromatase inhibitors (AIs) as
monotherapy or combined with gonadotropin-releasing hormone (GnRH) analogue in male …

Objective: To review presentation, diagnosis, treatment and prognosis of male breast
cancer. Method: A systematic review of the English language literature between 1990 and …